Equities

Ortin Global Ltd

ORTINGLOBE:NSI

Ortin Global Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)20.86
  • Today's Change-0.34 / -1.60%
  • Shares traded10.53k
  • 1 Year change+6.43%
  • Beta1.9421
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments232.565.95
Total Receivables, Net183432
Total Inventory0.502617
Prepaid expenses------
Other current assets, total222.651.77
Total current assets636557
Property, plant & equipment, net0.12144146
Goodwill, net------
Intangibles, net------
Long term investments2.342.710.00
Note receivable - long term----3.17
Other long term assets------
Total assets67212207
LIABILITIES
Accounts payable0.78157.87
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases03544
Other current liabilities, total201924
Total current liabilities207076
Total long term debt183017
Total debt186461
Deferred income tax02.542.71
Minority interest------
Other liabilities, total01.351.37
Total liabilities3810397
SHAREHOLDERS EQUITY
Common stock818181
Additional paid-in capital------
Retained earnings (accumulated deficit)(53)2728
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity28109110
Total liabilities & shareholders' equity67212207
Total common shares outstanding8.138.138.13
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.